Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch E.
Zhou L, et al.
Oncogene. 2016 May;35(21):2687-97. doi: 10.1038/onc.2015.343. Epub 2015 Sep 14.
Oncogene. 2016.
PMID: 26364599
Free PMC article.